OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
4
Results
Show all
Save search
Copy query
Show results for
Unknown
(3)
Proteomics
(1)
Organisms
Mus musculus
(1)
Repository
pride
(1)
Tissue
Macrophage
(1)
Primary cell
(1)
Disease
Colon cancer
(1)
Technology Type
Gel-based experiment
(1)
Mass Spectrometry
(1)
Shotgun proteomics
(1)
Publication Date
2022
(1)
Release Date
2024
(1)
2015
(1)
2021
(1)
Lab affiliation
Therapeutics & Biotechnology Division, Drug Discovery Platform Research Center, Korea Research Institute of Chemical Technology (KRICT),
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Cryo electron tomography of the reconstituted TRIM72-proteoliposomes on both positive and negative curvatures.
Not available
EMPIAR-10690
|
biostudies-other
Cite
Weekly docetaxel and gemcitabine in previously treated metastatic esophageal squamous cell carcinoma.
Not available
S-EPMC4394089
|
biostudies-literature
Cite
Proteomics based analysis for associated PD-L1 in macrophage stimulated with extracellular adenosine signaling
We performed proteomics analysis to discover effector proteins for the post-transcriptional regulation of PD-L1 onhuman macrophages stimulated by adenosine signal.
ORGANISM(S):
Mus musculus (Mouse)
2022-10-14
|
PXD024512
|
Pride
Macrophage adenosin
Cite
A Randomized, Multi-Center, Open Label Study to Compare the Safety and Efficacy between Afatinib Monotherapy and Combination Therapy with HAD-B1 for the Locally Advanced or Metastatic NSCLC Patients with EGFR Mutations.
Not available
S-EPMC11301725
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets